Christopher Traenka Selected Research

Ischemic Stroke

1/2022	Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage.
11/2021	Oral Anticoagulants in Atrial Fibrillation Patients With Recent Stroke Who Are Dependent on the Daily Help of Others.
1/2021	Cervical and intracranial artery dissections.
1/2021	Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
2/2020	Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation.
11/2019	Intravenous thrombolysis for suspected ischemic stroke with seizure at onset.
3/2018	Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke - Results from the SWISS registry.
1/2018	Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.
12/2017	Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.
1/2017	Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher Traenka Research Topics

Disease

18	Stroke (Strokes) 01/2022 - 05/2015
12	Ischemic Stroke 01/2022 - 09/2015
5	Cerebral Hemorrhage 01/2022 - 05/2017
5	Blood Vessel Dissection 01/2021 - 06/2017
4	Atrial Fibrillation 11/2021 - 01/2016
4	Hemorrhage 11/2021 - 09/2015
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 11/2016
2	Hematoma 11/2018 - 05/2017
1	Transient Ischemic Attack 01/2022
1	Infarction (Infarctions) 09/2020
1	Ischemia 09/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hypercholesterolemia 01/2020
1	Hemorrhagic Stroke 01/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2015
1	Pathologic Constriction (Stenosis) 05/2015
1	Neoplasms (Cancer) 10/2010
1	Medulloblastoma 10/2010

Drug/Important Bio-Agent (IBA)

14	AnticoagulantsIBA 01/2022 - 09/2015
10	Vitamin K FDA Link 01/2022 - 09/2015
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 09/2020
3	N(4)-oleylcytosine arabinosideIBA 11/2018 - 09/2015
3	RivaroxabanIBA 01/2018 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 05/2015
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	AcenocoumarolIBA 01/2021
1	Phenprocoumon (Liquamar)FDA Link 01/2021
1	Extracellular Matrix ProteinsIBA 10/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	Retinaldehyde (Retinal)IBA 09/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2017
1	Transforming Growth Factor-beta Type II ReceptorIBA 06/2017
1	NucleotidesIBA 06/2017
1	Factor Xa (Coagulation Factor Xa)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	2,6-dinitrotoluene (DNT)IBA 01/2017
1	Messenger RNA (mRNA)IBA 10/2010
1	Proteins (Proteins, Gene)FDA Link 10/2010
1	Small Interfering RNA (siRNA)IBA 10/2010

Therapy/Procedure

6	Therapeutics 01/2021 - 09/2015
2	Secondary Prevention 02/2020 - 11/2016
1	Contraindications 11/2019
1	Endarterectomy (Thromboendarterectomy) 06/2019
1	Aftercare (After-Treatment) 01/2017